Elihu H. Estey

64.7k citations

687 papers · 39.7k indexed · 9 hit papers · h-index 100

Hematology top 0.01%
- Acute Myeloid Leukemia Research 509
- Chronic Myeloid Leukemia Treatments 110
- Hematopoietic Stem Cell Transplantation 85
- Multiple Myeloma Research and Treatments 73
Genetics top 0.02%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 74
Oncology top 0.1%
- Neutropenia and Cancer Infections 76
Public Health, Environmental and Occupational Health top 0.02%
- Acute Lymphoblastic Leukemia research 168
Molecular Biology top 0.1%
- Retinoids in leukemia and cellular processes 75

Co-authors: Hagop M. Kantarjian Michael J. Keating Hartmut Döhner Jörge E. Cortes Frederick R. Appelbaum Susan O’Brien Sherry Pierce Francis J. Giles
Cited by: Hematology Genetics Oncology
Partner nations: United States South Africa United Kingdom

In The Last Decade

Elihu H. Estey

672 papers receiving 38.8k citations

Hit Papers

9 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2018 Acute myeloid leukemia: 2019 update on risk‐stratification and management
2014 Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials
2009 Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
2008 Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
2006 Acute myeloid leukaemia
2003 Revised Recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia
2001 Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse
2000 Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes
1997 Engraftment of Allogeneic Hematopoietic Progenitor Cells With Purine Analog-Containing Chemotherapy: Harnessing Graft-Versus-Leukemia Without Myeloablative Therapy

Peers

Countries citing papers authored by Elihu H. Estey

Since Specialization

Citations

This map shows the geographic impact of Elihu H. Estey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elihu H. Estey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elihu H. Estey more than expected).

Fields of papers citing papers by Elihu H. Estey

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elihu H. Estey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elihu H. Estey. The network helps show where Elihu H. Estey may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Elihu H. Estey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elihu H. Estey Line = papers co-authored together Elihu H. Estey links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Poor post-induction outcomes in patients with acute myeloid leukemia previously treated with hypomethylating agents Michelle Y. Zhang,Megan Othus,Carole Shaw,Kelda Schonhoff,Anna B. Halpern,Jacob Appelbaum,Paul C. Hendrie,Roland B. Walter,Elihu H. Estey,Mary‐Elizabeth M. Percival	2023	1
2	Phase II study of dose-adjusted EPOCH as initial therapy for adults with high-risk acute lymphoblastic leukemia Ryan D. Cassaday,Lucas C. Zarling,Kelsey‐Leigh A. Garcia,Olga Sala‐Torra,Philip A. Stevenson,Christen H. Martino,Yajuan J. Liu,Min Fang,Mary‐Elizabeth M. Percival,Anna B. Halpern,Pamela S. Becker,Vivian G. Oehler,Andrei R. Shustov,Jason P. Cooper,Johnnie J. Orozco,Paul C. Hendrie,Roland B. Walter,Jerald P. Radich,Lorinda Soma,Elihu H. Estey	2023	4
3	Lamin B1 deletion in myeloid neoplasms causes nuclear anomaly and altered hematopoietic stem cell function Andreea Reilly,J. Philip Creamer,Sintra Stewart,Massiel Chavez Stolla,Yuchuan Wang,Jing Du,Rachel Wellington,Stephanie Busch,Elihu H. Estey,Pamela S. Becker,Min Fang,Sioḃán Keel,Janis L. Abkowitz,Lorinda Soma,Jian Ma,Zhijun Duan,Sergei Doulatov	2022	25
4	Evaluating concordance in assessment of ECOG performance status in acute myeloid leukemia patients Nicole Mostofi,Carole Shaw,Roland B. Walter,Mary‐Elizabeth M. Percival,Elihu H. Estey	2022	1
5	Comparative analysis of infectious complications with outpatient vs. inpatient care for adults with high-risk myeloid neoplasm receiving intensive induction chemotherapy Anna B. Halpern,Megan Othus,Nicholas P. Howard,Paul C. Hendrie,Mary‐Elizabeth M. Percival,Garrett A. Hartley,Verna Welch,Elihu H. Estey,Roland B. Walter	2021	2
6	Regimen‐intensity per count‐recovery and hospitalization index: A new tool to assign regimen intensity for AML Mohamed L. Sorror,Shirali Agarwal,Megan Othus,Ylinne Lynch,Jennifer E. Nyland,Mary‐Elizabeth M. Percival,Pamela S. Becker,Frederick R. Appelbaum,Elihu H. Estey	2020	1
7	Phase 2 study of pembrolizumab for measurable residual disease in adults with acute lymphoblastic leukemia Ryan D. Cassaday,Kelsey‐Leigh A. Garcia,Jonathan R. Fromm,Mary‐Elizabeth M. Percival,Cameron J. Turtle,Paul Nghiem,P. Stevenson,Elihu H. Estey	2020	19
8	Prognostic Significance of NPM1 Mutations in the Absence of FLT3 –Internal Tandem Duplication in Older Patients With Acute Myeloid Leukemia: A SWOG and UK National Cancer Research Institute/Medical Research Council Report Fabiana Ostronoff,Megan Othus,Michelle Lazenby,Elihu H. Estey,Frederick R. Appelbaum,Anna Evans,John E. Godwin,Amanda Gilkes,Kenneth J. Kopecky,Alan K. Burnett,Alan F. List,Min Fang,Vivian G. Oehler,Stephen H. Petersdorf,Era L. Pogosova‐Agadjanyan,Jerald P. Radich,Cheryl L. Willman,Soheil Meshinchi,Derek L. Stirewalt	2015	96
9	Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia: Time to Move Toward a Minimal Residual Disease–Based Definition of Complete Remission? Daisuke Araki,Brent L. Wood,Megan Othus,Jerald P. Radich,Anna B. Halpern,Yi Zhou,Marco Mielcarek,Elihu H. Estey,Frederick R. Appelbaum,Roland B. Walter	2015	258
10	Preclinical and Early Clinical Evaluation of the Oral AKT Inhibitor, MK-2206, for the Treatment of Acute Myelogenous Leukemia Marina Konopleva,Roland B. Walter,Stefan Faderl,Elias Jabbour,Zhihong Zeng,Gautam Borthakur,Xuelin Huang,Tapan M. Kadia,Peter P. Ruvolo,Jennie B. Feliu,Hongbo Lu,LaKiesha Debose,Jan A. Burger,Michael Andreeff,Wenbin Liu,Keith Baggerly,Steven M. Kornblau,L. Austin Doyle,Elihu H. Estey,Hagop M. Kantarjian	2014	70
11	Prediction of Early Death After Induction Therapy for Newly Diagnosed Acute Myeloid Leukemia With Pretreatment Risk Scores: A Novel Paradigm for Treatment Assignment Roland B. Walter,Megan Othus,Gautam Borthakur,Farhad Ravandi,Jörge E. Cortes,Sherry Pierce,Frederick R. Appelbaum,Hagop Kantarjian,Elihu H. Estey	2011	244
12	Constitutional hypomorphic telomerase mutations in patients with acute myeloid leukemia Rodrigo T. Calado,Joshua A. Regal,Mark Hills,William T. Yewdell,Leandro F. Dalmazzo,Marco A. Zago,Peter M. Lansdorp,Donna E. Hogge,Stephen J. Chanock,Elihu H. Estey,Roberto Passetto Falcão,Neal S. Young	2009	125
13	Proteasome Enzymatic Activities in Plasma as Risk Stratification of Patients with Acute Myeloid Leukemia and Advanced-Stage Myelodysplastic Syndrome Wanlong Ma,Hagop M. Kantarjian,B. Nebiyou Bekele,Amber C. Donahue,Xi Zhang,Zhong J. Zhang,Susan O’Brien,Elihu H. Estey,Zeev Estrov,Jörge E. Cortes,Michael J. Keating,Francis J. Giles,Maher Albitar	2009	40
14	Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetbreakdown → Hartmut Döhner,Elihu H. Estey,Sergio Amadori,Frederick R. Appelbaum,Thomas Büchner,Alan K. Burnett,Hervé Dombret,Pierre Fenaux,David Grimwade,Richard A. Larson,Francesco Lo‐Coco,Tomoki Naoe,Dietger Niederwieser,Gert J. Ossenkoppele,Miguel Á. Sanz,Jorge Sierra,Martin S. Tallman,Bob Löwenberg,Clara D. Bloomfield	2009	2350
15	Targeting the leukemia microenvironment by CXCR4 inhibition overcomes resistance to kinase inhibitors and chemotherapy in AML Zhihong Zeng,Yue Shi,Ismael Samudio,Rui-Yu Wang,Xiaoyang Ling,Olga Frolova,Mark J. Levis,Joshua B. Rubin,Robert Negrin,Elihu H. Estey,Sergej Konoplev,Michael Andreeff,Marina Konopleva	2008	397
16	Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients Mikkael A. Sekeres,Paul Elson,Matt Kalaycio,Anjali S. Advani,Edward A. Copelan,Stefan Faderl,Hagop M. Kantarjian,Elihu H. Estey	2008	146
17	Randomized Comparison of Cooked and Noncooked Diets in Patients Undergoing Remission Induction Therapy for Acute Myeloid Leukemia Alison Gardner,Gloria Mattiuzzi,Stefan Faderl,Gautam Borthakur,Guillermo Garcia‐Manero,Sherry Pierce,Mark Brandt,Elihu H. Estey	2008	84
18	RIL , a LIM Gene on 5q31, Is Silenced by Methylation in Cancer and Sensitizes Cancer Cells to Apoptosis Yanis Boumber,Yutaka Kondo,Xuqi Chen,Lanlan Shen,Vazganush Gharibyan,Kazuo Konishi,Elihu H. Estey,Hagop M. Kantarjian,Guillermo Garcia‐Manero,Jean‐Pierre J. Issa	2007	56
19	Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia Michele Stanislaw Milella,Steven M. Kornblau,Zeev Estrov,Bing Z. Carter,Hélène Lapillonne,David Harris,Marina Konopleva,Shourong Zhao,Elihu H. Estey,Michael Andreeff	2001	14
20	Treatment of acute myelogenous leukemia with chemotherapy and hematopoietic growth factors Elihu H. Estey,K. B. McCredie,Michael J. Keating,Hagop M. Kantarjian,Razelle Kurzrock,Moshe Talpaz,Jordan U. Gutterman,A. B. Deisseroth	1990	2

About Elihu H. Estey

Elihu H. Estey is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 687 papers that have together received 39.7k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (509 papers), Acute Lymphoblastic Leukemia research (168 papers), Chronic Myeloid Leukemia Treatments (110 papers), Hematopoietic Stem Cell Transplantation (85 papers), Neutropenia and Cancer Infections (76 papers), Retinoids in leukemia and cellular processes (75 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (74 papers) and Multiple Myeloma Research and Treatments (73 papers). The work is most often cited by research in Hematology (27.6k citations), Genetics (8.7k citations) and Oncology (8.6k citations). Elihu H. Estey has collaborated with scholars based in United States, South Africa and United Kingdom. Frequent co-authors include Hagop M. Kantarjian, Michael J. Keating, Hartmut Döhner, Jörge E. Cortes, Frederick R. Appelbaum, Susan O’Brien, Sherry Pierce, Francis J. Giles, Maher Albitar and Emil J. Freireich.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact